Plewig and Kligman's Acne and Rosacea

Total Page:16

File Type:pdf, Size:1020Kb

Plewig and Kligman's Acne and Rosacea Plewig and Kligman’s Acne and Rosacea Gerd Plewig • Bodo Melnik • WenChieh Chen Plewig and Kligman’s Acne and Rosacea Fourth Edition Gerd Plewig Bodo Melnik Department of Dermatology and Allergy Department of Dermatology Ludwig-Maximilian-University Munich Environmental Medicine and Health Theory Munich University of Osnabrück Germany Osnabrück Germany WenChieh Chen Department of Dermatology and Allergy Technical University of Munich Munich Germany ISBN 978-3-319-49273-5 ISBN 978-3-319-49274-2 (eBook) https://doi.org/10.1007/978-3-319-49274-2 © Springer Nature Switzerland AG 1975, 1993, 2000, 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland In Memory of Albert Montgomery Kligman, M.D., Ph.D., Dr. hc. mult. Philadelphia 17 March 1916–Philadelphia 9 February 2010 Mentor—Teacher—Scientist—Physician—Friend (Portrait. Oil on canvas, painted in 1995 by John Boyd Martin, who is born in 1936 Located outside the laboratory named for Albert M. Kligman, Biochemical Research Building, Department of Dermatology, University of Pennsylvania, Philadelphia With kind permission, George Cotsarelis, M.D., Ph.D., Professor and Chairman) To our wives, Helga, Susanne, and Pei-Hsiu Preface to the Fourth Edition More than 50 years have elapsed since the first publication of this book, compiled and written with the brilliant ideas and energy of Albert Montgomery Kligman (1916–2010) from Philadelphia, one of the greatest experimental and clinical dermatologists of his time. Sadly enough, we miss him as an author of this new work but express our deepest gratitude to a life- long teacher, mentor, and friend. After the English editions (1975, 1993, 2000) and German editions (1978, 1994), time was ready for a new team of authors to continue this monograph. Colleagues the world over encour- aged us to bring the vast new information on these common diseases, acne and rosacea, and also demodicosis and acne-associated autoinflammatory diseases into a new volume of text and atlas. The growth of basic knowledge coupled with clinical experience since has been enormous. This has been a joyous enterprise for us. The ability to treat acne and rosacea effectively was accompanied by the vastly expanded understanding of their etiologies and pathogenesis, thanks to the remarkable input of eminent researchers and clinicians worldwide. Acne is not only an eminently treatable disease; even worst cases, for example, acne con- globata and acne fulminans, are actually curable. No case is so severe as to be beyond help with the array of diverse drugs now available. Treatment failure is mostly physician failure. Prevention of acne in highly susceptible children is well possible with topical agents pre- scribed at the incipient stage, thus preventing the dreaded sequel of scarring. We continue in the beliefs expressed in 1975 regarding our mission. This text and atlas is dedicated to dermatologists and other colleagues who must diagnose and treat these disfigur- ing, remarkably protean, common diseases. This is a reference work for investigators, including a selective review of the literature. The references we cite have been selected for their relevance to daily practice, for their educational worth, and for their readability and historical impact. This meant for a massive culling of thou- sands of articles piled up in past decades. We apologize to those authors whose contributions are not listed here. A quote from the first edition epitomizes our current attitude: “We have sought to create a portfolio of still-life pictures of gross and microscopic anatomy of acne and rosacea. This will be a photographic record of what these maladies look like, their usual and unusual features…” The views we present in respect to pathogenesis and treatment are in the first place our own and much less constructed from recommendations of other authorities. Thus, some of our pro- posals may not meet the stringent requirements of evidence-based medicine. Since this is a practice-orientated text, we have taken on the hazardous responsibility of expressing our per- sonal options and not the many alternatives which can be found in the literature. Consensus conferences and guidelines, based on national or international participation, are helpful but may not be applicable to regional or in loco demands. We do not wish to pretend that no quan- daries remain or that everything is simple and straightforward as our style might suggest. Over the past years, new concepts of pathogenesis, new variants, new syndromes of acne, and new therapies have emerged. To name but a few, these include autoinflammatory syn- dromes of acne associated with arthritis and pyoderma gangrenosum, hidradenitis suppurativa/­ vii viii Preface to the Fourth Edition acne inversa now redefined as dissecting terminal hair folliculitis, the role ofDemodex follicu- lorum mites in healthy people and diseased state, and the role of microbiota and biofilm. There is evidence to support our hypotheses concerning signal transduction pathways such as the role of FoxO1 and mTORC1 in acne, endoplasmic reticulum stress responses in rosacea, and the T cells and Th17 cells in dissecting terminal hair folliculitis, the impact of hyperglycemic food and milk, and the p53-associated sebocyte apoptosis caused by isotretinoin. Newly introduced drugs and topical remedies were discussed. Many acne-mimicking diseases are commonplace but can be confusing. Acne, syndromic constellations of acne, and rosacea not infrequently coexist in overlap mixtures, which may be present at the same time, with one slowly disappear- ing and the other emerging. Physicians must keep abreast with this fascinating new wealth of science. Our patients expect that we physicians have enough time for them, listening is as important as looking. Even today, our well-educated patients and their custodians sometimes hold a bag full of irrational folkloristic beliefs and myths, which need to be dispelled. It is well accepted that placebo effects are prominent in medicine and, of course, in acne and rosacea alike. This explains why some popular, unproven remedies seem to work. Even in properly controlled studies, it is astonishing how often the efficacy of the vehicle approaches that of the active drug. Important regular changes took place in the last decades. Acne conglobata and severe inflammatory acne seem to be on the wane, possibly as the result of so effective treatments such as isotretinoin, oral antibiotics, and new topical formulations. Rosacea seems to steadily increase. We speculate that also epidemiological changes reflect the environmental exposure and nutrition. Furthermore, migration across continents and countries with new in loco cir- cumstances of health care and living standards may have their impact on expression of these dermatoses. Fascinating are the enormous steps forward of surgical interventions with lasers, fillers, and peels, as they all revolutionized our treatment possibilities. Highly specialized colleagues have become masters in this field. The reader is referred to the most experienced authorities in this rapidly moving field. Munich, Germany Gerd Plewig Osnabrück, Germany Bodo Melnik Munich, Germany WenChieh Chen Acknowledgments It is with joy that we thank so many highly skilled professionals who generously helped to recreate this book. Our gratitude for their superb collaboration is acknowledged herewith. Our thanks are but a small recompense for their contributions. Mr. Peter Bilek (1936–2009), master of photography, Department of Dermatology, Ludwig-­ Maximilian-­University Munich. Mr. Winfried Neuse, retired photographer, photo designer, and enthusiastic artist with the camera, Department of Dermatology, Heinrich-Heine-University Düsseldorf. Privatdozent Dr. Thomas Jansen, Duesseldorf, contributed faithfully to the 1994 and 2000 editions. Professor Dr. Helmut H. Wolff and Mrs. Elfriede Januschke, medical technician, formerly in the Department of Dermatology, Ludwig-Maximilian-University Munich, contributed to the exquisite transmission electron microscopies. Professor Dr. med., Dr. h.c. mult. Thomas Ruzicka, former chairman of the Munich Department, generously provided unrestricted access to essential sections of the clinic
Recommended publications
  • Chloracne: from Clinic to Research
    DERMATOLOGICA SINICA 30 (2012) 2e6 Contents lists available at SciVerse ScienceDirect Dermatologica Sinica journal homepage: http://www.derm-sinica.com REVIEW ARTICLE Chloracne: From clinic to research Qiang Ju 1, Kuochia Yang 2, Christos C. Zouboulis 3, Johannes Ring 4, Wenchieh Chen 4,* 1 Department of Dermatology, Shanghai Skin Disease and STD Hospital, Shanghai, People’s Republic of China 2 Department of Dermatology, Changhua Christian Hospital, Changhua, Taiwan 3 Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany 4 Department of Dermatology and Allergy, Technische Universität München, Munich, Germany article info abstract Article history: Chloracne is the most sensitive and specific marker for a possible dioxin (2,3,7,8-tetrachlorodibenzo-p- Received: Oct 31, 2011 dioxin) intoxication. It is clinically characterized by multiple acneiform comedone-like cystic eruptions Revised: Nov 9, 2011 mainly involving face in the malar, temporal, mandibular, auricular/retroauricular regions, and the Accepted: Nov 9, 2011 genitalia, often occurring in age groups not typical for acne vulgaris. Histopathology is essential for adefinite diagnosis, which exhibits atrophy or absence of sebaceous glands as well as infundibular Keywords: dilatation or cystic formation of hair follicles, hyperplasia of epidermis, and hyperpigmentation of aryl hydrocarbon receptor stratum corneum. The appearance of chloracne and its clinical severity does not correlate with the blood chloracne “ ” 2,3,7,8-tetrachlorodibenzo-p-dioxin levels of dioxins. Pathogenesis of chloracne remains largely unclear. An aryl hydrocarbon receptor - polyhalogenated aromatic hydrocarbons mediated signaling pathway affecting the multipotent stem cells in the pilosebaceous units is probably sebaceous gland the major molecular mechanism inducing chloracne.
    [Show full text]
  • (CD-P-PH/PHO) Report Classification/Justifica
    COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) Report classification/justification of medicines belonging to the ATC group D07A (Corticosteroids, Plain) Table of Contents Page INTRODUCTION 4 DISCLAIMER 6 GLOSSARY OF TERMS USED IN THIS DOCUMENT 7 ACTIVE SUBSTANCES Methylprednisolone (ATC: D07AA01) 8 Hydrocortisone (ATC: D07AA02) 9 Prednisolone (ATC: D07AA03) 11 Clobetasone (ATC: D07AB01) 13 Hydrocortisone butyrate (ATC: D07AB02) 16 Flumetasone (ATC: D07AB03) 18 Fluocortin (ATC: D07AB04) 21 Fluperolone (ATC: D07AB05) 22 Fluorometholone (ATC: D07AB06) 23 Fluprednidene (ATC: D07AB07) 24 Desonide (ATC: D07AB08) 25 Triamcinolone (ATC: D07AB09) 27 Alclometasone (ATC: D07AB10) 29 Hydrocortisone buteprate (ATC: D07AB11) 31 Dexamethasone (ATC: D07AB19) 32 Clocortolone (ATC: D07AB21) 34 Combinations of Corticosteroids (ATC: D07AB30) 35 Betamethasone (ATC: D07AC01) 36 Fluclorolone (ATC: D07AC02) 39 Desoximetasone (ATC: D07AC03) 40 Fluocinolone Acetonide (ATC: D07AC04) 43 Fluocortolone (ATC: D07AC05) 46 2 Diflucortolone (ATC: D07AC06) 47 Fludroxycortide (ATC: D07AC07) 50 Fluocinonide (ATC: D07AC08) 51 Budesonide (ATC: D07AC09) 54 Diflorasone (ATC: D07AC10) 55 Amcinonide (ATC: D07AC11) 56 Halometasone (ATC: D07AC12) 57 Mometasone (ATC: D07AC13) 58 Methylprednisolone Aceponate (ATC: D07AC14) 62 Beclometasone (ATC: D07AC15) 65 Hydrocortisone Aceponate (ATC: D07AC16) 68 Fluticasone (ATC: D07AC17) 69 Prednicarbate (ATC: D07AC18) 73 Difluprednate (ATC: D07AC19) 76 Ulobetasol (ATC: D07AC21) 77 Clobetasol (ATC: D07AD01) 78 Halcinonide (ATC: D07AD02) 81 LIST OF AUTHORS 82 3 INTRODUCTION The availability of medicines with or without a medical prescription has implications on patient safety, accessibility of medicines to patients and responsible management of healthcare expenditure. The decision on prescription status and related supply conditions is a core competency of national health authorities.
    [Show full text]
  • Compensation for Occupational Skin Diseases
    ORIGINAL ARTICLE http://dx.doi.org/10.3346/jkms.2014.29.S.S52 • J Korean Med Sci 2014; 29: S52-58 Compensation for Occupational Skin Diseases Han-Soo Song1 and Hyun-chul Ryou2 The Korean list of occupational skin diseases was amended in July 2013. The past list was constructed according to the causative agent and the target organ, and the items of that 1 Department of Occupational and Environmental list had not been reviewed for a long period. The revised list was reconstructed to include Medicine, College of Medicine, Chosun University, Gwangju; 2Teo Center of Occupational and diseases classified by the International Classification of Diseases (10th version). Therefore, Environmental Medicine, Changwon, Korea the items of compensable occupational skin diseases in the amended list in Korea comprise contact dermatitis; chemical burns; Stevens-Johnson syndrome; tar-related skin diseases; Received: 19 December 2013 infectious skin diseases; skin injury-induced cellulitis; and skin conditions resulting from Accepted: 2 May 2014 physical factors such as heat, cold, sun exposure, and ionized radiation. This list will be Address for Correspondence: more practical and convenient for physicians and workers because it follows a disease- Han-Soo Song, MD based approach. The revised list is in accordance with the International Labor Organization Department of Occupational and Environmental Medicine, Chosun University Hospital, 365 Pilmun-daero, Dong-gu, list and is refined according to Korean worker’s compensation and the actual occurrence of Gwangju 501-717, Korea occupational skin diseases. However, this revised list does not perfectly reflect the actual Tel: +82.62-220-3689, Fax: +82.62-443-5035 E-mail: [email protected] status of skin diseases because of the few cases of occupational skin diseases, incomplete statistics of skin diseases, and insufficient scientific evidence.
    [Show full text]
  • General Dermatology an Atlas of Diagnosis and Management 2007
    An Atlas of Diagnosis and Management GENERAL DERMATOLOGY John SC English, FRCP Department of Dermatology Queen's Medical Centre Nottingham University Hospitals NHS Trust Nottingham, UK CLINICAL PUBLISHING OXFORD Clinical Publishing An imprint of Atlas Medical Publishing Ltd Oxford Centre for Innovation Mill Street, Oxford OX2 0JX, UK tel: +44 1865 811116 fax: +44 1865 251550 email: [email protected] web: www.clinicalpublishing.co.uk Distributed in USA and Canada by: Clinical Publishing 30 Amberwood Parkway Ashland OH 44805 USA tel: 800-247-6553 (toll free within US and Canada) fax: 419-281-6883 email: [email protected] Distributed in UK and Rest of World by: Marston Book Services Ltd PO Box 269 Abingdon Oxon OX14 4YN UK tel: +44 1235 465500 fax: +44 1235 465555 email: [email protected] © Atlas Medical Publishing Ltd 2007 First published 2007 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of Clinical Publishing or Atlas Medical Publishing Ltd. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. A catalogue record of this book is available from the British Library ISBN-13 978 1 904392 76 7 Electronic ISBN 978 1 84692 568 9 The publisher makes no representation, express or implied, that the dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations.
    [Show full text]
  • Aswathy. P Aravind S, Ayurvedic Concept of Wellness
    P a g e | 91 Editorial . International Research Journal of Ayurveda & Yoga An International Peer Reviewed Journal for Ayurveda & Yoga Management of Skin Allergy Due to Cosmetic Products -A Conceptual Study Dr. Monika Sharma 1 Dr. Rajveer Sason2, Dr. Sandeep Charak3 ICV-70.44- ISRA-1.318 VOLUME 4 ISSUE 4 1. Ph.D Scholar, P.G Department of Agad tantra Nia Jaipur Rajasthan. 2. Ph.D Scholar, P.G Department of Agad tantra Nia Jaipur Rajasthan. 3. Assistance Professor, Dept. of Agad Tantra, GAMC, Jammu & Kashmir. Corresponding Author :- Dr. Monika Sharma Ph.D Scholar, P.G Department of Agad tantra Nia Jaipur Rajasthan, Email: [email protected] Article received on 2nd April 2021 Article Accepted 20th April 2021 Article published 30th April 2021 ABSTRACT: - Beauty is a subject of social medical importance. Every person wants to stand at height and they require distinct personality which differ them from a crowd. People are using cosmetic products use for curing their skin problems and to maintain the skin appearance and beauty. Allergic reactions due to cosmetics may be delayed type reactions such as photo allergic contact dermatitis and immediate type reactions, that is contact dermatitis. Prick test is gold standard for diagnosis of allergy produce by cosmetic products. According to Ayurveda, if the body balance is maintained no allergic reactions are possible. All Skin disease have been described under Kustha (Psoriasis). Present paper highlights skin allergy produces by cosmetic products and its management through Ayurveda. Keywords-Skin allergy, Cosmetic product, Management This work is licensed under a creative attribution -Non-commercial-No derivatives 4.0 International License commons How to cite this article: - Dr.
    [Show full text]
  • Canadian Clinical Practice Guideline on the Management of Acne (Full Guideline)
    Appendix 4 (as supplied by the authors): Canadian Clinical Practice Guideline on the Management of Acne (full guideline) Asai, Y 1, Baibergenova A 2, Dutil M 3, Humphrey S 4, Hull P 5, Lynde C 6, Poulin Y 7, Shear N 8, Tan J 9, Toole J 10, Zip C 11 1. Assistant Professor, Queens University, Kingston, Ontario 2. Private practice, Markham, Ontario 3. Assistant Professor, University of Toronto, Toronto, Ontario 4. Clinical Assistant Professor, University of British Columbia, Vancouver, British Columbia 5. Professor, Dalhousie University, Halifax, Nova Scotia 6. Associate Professor, University of Toronto, Toronto, Ontario 7. Associate Clinical Professor, Laval University, Laval, Quebec 8. Professor, University of Toronto, Toronto, Ontario 9. Adjunct Professor, University of Western Ontario, Windsor, Ontario 10. Professor, University of Manitoba, Winnipeg, Manitoba 11. Clinical Associate Professor, University of Calgary, Calgary, Alberta Appendix to: Asai Y, Baibergenova A, Dutil M, et al. Management of acne: Canadian clinical practice guideline. CMAJ 2015. DOI:10.1503/cmaj.140665. Copyright © 2016 The Author(s) or their employer(s). To receive this resource in an accessible format, please contact us at [email protected]. Contents List of Tables and Figures ............................................................................................................. v I. Introduction ................................................................................................................................ 1 I.1 Is a Clinical Practice Guideline
    [Show full text]
  • Skin of Color
    Dermatology Patient Education Skin of Color There are a variety of skin, hair and nail conditions that are common in people with skin of color such as African Americans, Asians, Latinos and Native Americans. Your dermatologist can help diagnose and treat these skin conditions. SKIN CONDITIONS Postinflammatory hyperpigmentation (PIH) This condition results in patches of darker skin as your skin heals after a cut or scrape, or when acne, eczema or other rashes clear. PIH often fades, but the darker the PIH, the longer fading can take. Your dermatologist can help restore your skin’s color more quickly. Prescription medicines containing retinoids or hydroquinone (a bleaching ingredient), and procedures such as chemical peels and microdermabrasion may help. Your dermatologist will also encourage you to wear sunscreen to avoid further darkening of the skin due to ultraviolet (UV) light exposure and prevent further PIH from developing. Treatment products available over-the-counter rarely help and can make PIH more noticeable. Melasma This common condition causes brown to gray-brown patches, usually on the face. It occurs most often in women who have Latina, African, or Asian ancestry. Men can get melasma, too. Melasma can also appear on other parts of the body that get lots of sun exposure, such as the forearms and neck. Melasma may be associated with pregnancy, birth control pills or estrogen replacement therapy. It may also be hereditary. Melasma can fade on its own, but it often recurs. Your dermatologist can provide prescription topical treatment to help the condition fade. Procedures including chemical peels and microdermabrasion can also help.
    [Show full text]
  • Copyrighted Material
    1 Index Note: Page numbers in italics refer to figures, those in bold refer to tables and boxes. References are to pages within chapters, thus 58.10 is page 10 of Chapter 58. A definition 87.2 congenital ichthyoses 65.38–9 differential diagnosis 90.62 A fibres 85.1, 85.2 dermatomyositis association 88.21 discoid lupus erythematosus occupational 90.56–9 α-adrenoceptor agonists 106.8 differential diagnosis 87.5 treatment 89.41 chemical origin 130.10–12 abacavir disease course 87.5 hand eczema treatment 39.18 clinical features 90.58 drug eruptions 31.18 drug-induced 87.4 hidradenitis suppurativa management definition 90.56 HLA allele association 12.5 endocrine disorder skin signs 149.10, 92.10 differential diagnosis 90.57 hypersensitivity 119.6 149.11 keratitis–ichthyosis–deafness syndrome epidemiology 90.58 pharmacological hypersensitivity 31.10– epidemiology 87.3 treatment 65.32 investigations 90.58–9 11 familial 87.4 keratoacanthoma treatment 142.36 management 90.59 ABCA12 gene mutations 65.7 familial partial lipodystrophy neutral lipid storage disease with papular elastorrhexis differential ABCC6 gene mutations 72.27, 72.30 association 74.2 ichthyosis treatment 65.33 diagnosis 96.30 ABCC11 gene mutations 94.16 generalized 87.4 pityriasis rubra pilaris treatment 36.5, penile 111.19 abdominal wall, lymphoedema 105.20–1 genital 111.27 36.6 photodynamic therapy 22.7 ABHD5 gene mutations 65.32 HIV infection 31.12 psoriasis pomade 90.17 abrasions, sports injuries 123.16 investigations 87.5 generalized pustular 35.37 prepubertal 90.59–64 Abrikossoff
    [Show full text]
  • International Journal of Scientific Research
    ORIGINAL RESEARCH PAPER Volume-9 | Issue-1 | January-2020 | PRINT ISSN No. 2277 - 8179 | DOI : 10.36106/ijsr INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH TYPES AND VARIANTS OF ACNE Dermatology Shailee Patel ABSTRACT Acne occur when pores of skin are blocked with oil, dead skin, or bacteria. It can occur when excessive oil is produced by follicles, bacteria build up in pores, and dead skin cells accumulate in pores. All these problem contribute in development of pimple. Acne are majorly seen among teenagers but they can also occur in adults. There are varying from of acne, and their varying treatment. KEYWORDS 1.INTRODUCTION ulcerative colitis and Crohn's disease and syndromes, such as Acne is linked to the change in hormone level during puberty. Acne is a synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) and disorder that is seen worldwide. Acne is a disease of the teenagers but pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) can be seen even in newborn children and also adults. Age and gender syndromes. also play a very important role in onset of acne. Acne most commonly occur between the ages of 10-13 years. Girls have an earlier onset 3.4 Occupational Acne which easily contribute to the onset of puberty in girls than in boys. The Occupational acne is defined as development of acne-like lesions after disease severity in more in boys during the late adolescence. Acne exposure to occupational agents in persons not prone to develop acne mostly develops on areas of skin that have abundant oil glands, like the and who have not had acne before engaging in the said occupation.
    [Show full text]
  • A Comprehensive Review of Acne Vulgaris AK Mohiuddin1* 1Department of Pharmacy, World University of Bangladesh
    Symbiosis ISSN Online: 2378-1726 www.symbiosisonlinepublishing.com Review Article Clinical Research in Dermatology: Open Access Open Access A Comprehensive Review of Acne Vulgaris AK Mohiuddin1* 1Department of Pharmacy, World University of Bangladesh Received: May 25, 2019; Accepted: June 6, 2019; Published: June 17, 2019 *Corresponding author: AK Mohiuddin, Assistant Professor, Department of Pharmacy, World University of Bangladesh, 151/8, Green Road, Dhanmondi, Dhaka – 1205, Bangladesh. E-mail: [email protected]; Orcid Id: https://orcid.org/0000-0003-1596-9757. Abstract Acne, also known as acne vulgaris (AV), is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin. It is characterized by blackheads or whiteheads, pimples, oily skin, and possible scarring. An intact stratum corneum and barrier, normal natural moisturizing factor and hyaluronic acid levels, normal Aquaporin-3 (AQP3) expression (localized at the basal lateral membranes of collecting duct cells in the kidney), and balanced sebum secretion are qualities of the skin that fall in the middle of the oily–dry spectrum. Patients rarely, if ever, complain about reduced sebum production, but elevated sebum production, yielding oily skin that can be a precursor to acne, is a common Propionibacterium acnes in adolescence, under the complaint. Several factors are known to influence sebum production. AV is mostly triggered by impact,influence as of sebum normal levels circulating are usually dehydroepiandrosterone low in childhood, rise (DHEA). in the middle-to-late It is a very common teen years, skin disorder and remain which stable can presentinto the withseventh inflammatory and eighth and decades non- untilinflammatory endogenous lesions androgen chiefly synthesis on the face dwindles.
    [Show full text]
  • Steroid-Induced Rosacealike Dermatitis: Case Report and Review of the Literature
    CONTINUING MEDICAL EDUCATION Steroid-Induced Rosacealike Dermatitis: Case Report and Review of the Literature Amy Y-Y Chen, MD; Matthew J. Zirwas, MD RELEASE DATE: April 2009 TERMINATION DATE: April 2010 The estimated time to complete this activity is 1 hour. GOAL To understand steroid-induced rosacealike dermatitis (SIRD) to better manage patients with the condition LEARNING OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Explain the clinical features of SIRD, including the 3 subtypes. 2. Evaluate the multifactorial pathogenesis of SIRD. 3. Recognize the importance of a detailed patient history and physical examination to diagnose SIRD. INTENDED AUDIENCE This CME activity is designed for dermatologists and generalists. CME Test and Instructions on page 195. This article has been peer reviewed and approved Einstein College of Medicine is accredited by by Michael Fisher, MD, Professor of Medicine, the ACCME to provide continuing medical edu- Albert Einstein College of Medicine. Review date: cation for physicians. March 2009. Albert Einstein College of Medicine designates This activity has been planned and imple- this educational activity for a maximum of 1 AMA mented in accordance with the Essential Areas PRA Category 1 Credit TM. Physicians should only and Policies of the Accreditation Council for claim credit commensurate with the extent of their Continuing Medical Education through the participation in the activity. joint sponsorship of Albert Einstein College of This activity has been planned and produced in Medicine and Quadrant HealthCom, Inc. Albert accordance with ACCME Essentials. Dr. Chen owns stock in Merck & Co, Inc. Dr. Zirwas is a consultant for Coria Laboratories, Ltd, and is on the speakers bureau for Astellas Pharma, Inc, and Coria Laboratories, Ltd.
    [Show full text]
  • Common Dermatological Conditions
    Produced: 13/01/2017 Common Dermatological Conditions Dr Alvin Chong Senior Lecturer Dr Catherine Scarff Senior Lecturer Dr Laura Scardamaglia Clinical Senior Lecturer Produced: 13/01/2017 Learning objectives: Describe the common features of • Eczema variants and psoriasis • Acne and rosacea • Scabies • Understand the principles of investigation and treatment for common dermatological problems Produced: 13/01/2017 Case: A 22 year old student presents with 3 months of worsening rash. Not responding to 1% hydrocortisone cream. Produced: 13/01/2017 Erythematous, ill defined, scaly, patches in flexures Produced: 13/01/2017 Diagnosis: Atopic eczema Produced: 13/01/2017 Atopic Eczema • Genetic predisposition Clinical features (Family history) • Itchy ++ • Atopic triad • Erythematous - Asthma • Diffuse - Hayfever • Flexural- thinnest skin - Eczema • Worse in winter (dry) • Worse in summer (heat) Produced: 13/01/2017 Atopic Eczema Model Genetic Predisposition Environmental -Filaggrin mutation- Triggers Leads to reduced barrier •Irritants (soaps etc) function •Allergy •Heat •Infection (Staph.) •“Itch-scratch cycle” •Stress and anxiety 1. Palmer et al Nat. Genet. 38,441-6 Eczema Produced: 13/01/2017 Atopic eczema in an infant Produced: 13/01/2017 3 year old girl, eczema since infancy Produced: 13/01/2017 35 year old man with longstanding eczema mainly of the flexures. Produced: 13/01/2017 Lichenification: The result of chronic rubbing and scratching Produced: 13/01/2017 Eczema Variants Produced: 13/01/2017 Discoid Eczema • Eczema in annular disc
    [Show full text]